56. ベーチェット病 Behcet disease Clinical trials / Disease details

臨床試験数 : 81 / 薬物数 : 107 - (DrugBank : 30) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 116

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02648581 (ClinicalTrials.gov)	June 14, 2017	21/12/2015	Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With B ...	A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal An ...	Behçet Disease	Drug: Subcutaneous Ustekinumab	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	16	Phase 2	France
2	EUCTR2015-002190-37-FR (EUCTR)	30/10/2015	12/01/2016	A Study to Evaluate the Efficacy and Safety of Ustekinumab in patients with Behçet disease	A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ustekinumab, a Human Monoclonal An ...	Behçet diseaseSTELABEC-1: patients with oral ulcersSTELABEC-2 : patients with active posterior uveit ...	Trade Name: STELARA Product Name: STELARA INN or Proposed INN: Ustekinumab	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 2	France

First Previous1Next Last